Joseph De Leo

Biographic Data

ID1930970
NAMEJoseph De Leo
GIVEN NAMESJoseph
FAMILY NAMEDe Leo
SIGNATUREDE LEO J
AFFILIATIONSCentre for Compassionate Care, Hamilton, Ontario, Canada
VERIFIEDNo
TOTAL WORKS7
TOTAL CITATIONS7
AUTHOR COUNT7
EDITOR COUNT0
FIRST PUBLICATION YEAR2020
LATEST PUBLICATION YEAR2022
H-INDEX2

  • How Important Is a Guide Who Has Taken Psilocybin in Psilocybin-Assisted Therapy for Depression

    M Earleywine, Francis Low et al.ARTICLEJournal of Psychoactive Drugs2022

    Promising outcomes of Psilocybin-Assisted Therapy (PAT) for depression have generated concerted efforts to replicate, extend, and refine protocols to maximize efficacy. Psychotherapy research reveals that clients benefit most when important components of treatment align with their personal preferences. One open question related to PAT concerns the importance of the psilocybin experience of the guides (trained professionals present during acute ef…

  • Exploring the Credibility of Psilocybin-assisted Therapy and Cognitive-behavioral Therapy for Depression

    Brianna R Altman, M Earleywine et al.ARTICLEJournal of Psychoactive Drugs2022

    Depression treatments succeed with many but leave others unimproved, and they can generate concerns about side effects, time, and cost. Psilocybin has generated media attention and empirical support for antidepressant effects, but lay impressions of its effectiveness are unclear. Although perceptions of treatment credibility contribute to outcome, beliefs about the credibility of psilocybin-assisted therapy (PAT) among potential patients remain u…

  • Scoping Review of Experiential Measures from Psychedelic Research and Clinical Trials

    Zachary Herrmann, M Earleywine et al.ARTICLEJournal of Psychoactive Drugs2022

    Subjective responses to psychoactive drugs have served as intriguing windows into consciousness as well as useful predictors. Subjective reactions to psychedelic molecules are particularly interesting given how they covary with subsequent improvements associated with psychedelic-assisted treatments. Although links between subjective reactions and decreases in treatment-resistant clinical depression, end-of-life anxiety, and maladaptive consumptio…

  • Integration in Psychedelic-Assisted Treatments

    Open AccessM Earleywine, Francis Low et al.ARTICLEJournal of Humanistic Psychology2022Cited by: 5References: 21

    Integration therapy, an integral part of psychedelic-assisted treatment, usually includes sessions devoted to making meaning of relevant psychedelic experiences after subjective effects have subsided. As the psychedelic renaissance continues, offers for this integration therapy have proliferated. In the present project, semi-structured interviews with 30 integration therapists focused on definitions of integration as well as challenges and concer…

  • A Semantic Scale Network analysis of the revised Mystical Experiences Questionnaire

    Open AccessM Earleywine, Francis Low et al.ARTICLEJournal of Psychedelic Studies2022References: 60

    Background and aims Multiple laboratories have proposed measures of subjective effects of psychedelics as potential mediators of their therapeutic impact. Other work has identified individual differences that covary with subjective responses in informative ways. The range of potential measures of responses, traits, and outcomes is vast. Ideas for new measures are likely numerous. The field will progress efficiently if proposed new scales can add …

  • Cognitive Behavioral Therapy, Ketamine, and Combination Treatment for Depression

    M Earleywine, Brianna R Altman et al.ARTICLEJournal of Psychoactive Drugs2021

    Ketamine, a novel treatment for depression, has generated considerable interest and research. Few experiments address lay impressions of the credibility of ketamine treatment relative to another popular intervention for depression, CBT. Over 500 participants with depressive symptoms read descriptions of CBT, ketamine, and a treatment that combined the two. Descriptions included pros and cons of each approach. Participants found the combination tr…

  • Psychedelic-assisted psychotherapy for depression

    Open AccessM Earleywine, Joseph De LeoARTICLEJournal of Psychedelic Studies2020Cited by: 2References: 32

    Despite the popular support for psychedelics as aids for depression, academics and the public frequently overestimate the efficacy of available medications and psychotherapies. Metaanalyses reveal that antidepressant medications alone help only one in four patients and rarely surpass credible placebos. Their effects, though statistically significant, might not impress depressed patients themselves. Psychotherapies create better outcomes than anti…